The Challenge of Managing Atrial Fibrillation during Pregnancy.
Pregnancy Heart Team
antiarrhythmic drugs (AADs)
anticoagulants
atrial fibrillation (AF)
electrical cardioversion (ECV)
pregnancy
Journal
Reviews in cardiovascular medicine
ISSN: 1530-6550
Titre abrégé: Rev Cardiovasc Med
Pays: Singapore
ID NLM: 100960007
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
24
05
2023
revised:
14
07
2023
accepted:
03
08
2023
medline:
30
7
2024
pubmed:
30
7
2024
entrez:
30
7
2024
Statut:
epublish
Résumé
The incidence of atrial fibrillation (AF) during pregnancy increases with maternal age and with the presence of structural heart disorders. Early diagnosis and prompt therapy can considerably reduce the risk of thromboembolism. The therapeutic approach to AF during pregnancy is particularly challenging, and the maternal and fetal risks associated with the use of antiarrhythmic and anticoagulant drugs must be carefully evaluated. Moreover, the currently used thromboembolic risk scores have yet to be validated for the prediction of stroke during pregnancy. At present, electrical cardioversion is considered to be the safest and most effective strategy in women with hemodynamic instability. Beta-selective blockers are also recommended as the first choice for rate control. Antiarrhythmic drugs such as flecainide, propafenone and sotalol should be considered for rhythm control if atrioventricular nodal-blocking drugs fail. AF catheter ablation is currently not recommended during pregnancy. Overall, the therapeutic strategy for AF in pregnancy must be carefully assessed and should take into consideration the advantages and drawbacks of each aspect. A multidisciplinary approach with a "Pregnancy-Heart Team" appears to improve the management and outcome of these patients. However, further studies are needed to identify the most appropriate therapeutic strategies for AF in pregnancy.
Identifiants
pubmed: 39077579
doi: 10.31083/j.rcm2410279
pii: S1530-6550(23)01101-8
pmc: PMC11273119
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
279Informations de copyright
Copyright: © 2023 The Author(s). Published by IMR Press.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest. Fabiana Lucà, Stefania Angela Di Fusco, and Furio Colivicchi are serving as Guest Editors of this journal; Alaide Chieffo is serving as one of the Editorial Board members of this journal. We declare that Fabiana Lucà, Stefania Angela Di Fusco, Furio Colivicchi, and Alaide Chieffo had no involvement in the peer review of this article and have no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to Buddhadeb Dawn and Bernard Belhassen.